RCM TECHNOLOGIES Reports Higher Year-Over-Year Profit on Both the Quarter and Six-Month Windows

Bottom line

RCM TECHNOLOGIES, INC. filed a Form 10-Q under accession 0001437749-26-027653 with the Securities and Exchange Commission covering period-ended-2026-07-04, presenting unaudited condensed consolidated financial statements for the three-month reporting period the three months ended July 4, 2026 and the six-month year-to-date period the six months ended July 4, 2026, with the comparative three-month period the three months ended June 28, 2025 and six-month period the six months ended June 28, 2025.

Across both reporting windows, the company remained profitable on every profitability dimension captured in the filing evidence. Net Income (Loss) Attributable to Parent was a profit of $4,901,000 USD for the three-month reporting period the three months ended July 4, 2026, compared with a profit of $3,785,000 USD for the prior-year three-month period the three months ended June 28, 2025; the authorized machine comparison characterizes this as a year-over-year increase with the transition profit to profit. For the six-month year-to-date period the six months ended July 4, 2026, Net Income (Loss) Attributable to Parent was a profit of $8,745,000 USD, versus a profit of $7,971,000 USD for the six months ended June 28, 2025, also rising year-over-year on a profit-to-profit basis.

Operating Income (Loss) tracked the same shape. For the quarter, Operating Income (Loss) was a profit of $7,956,000 USD against a profit of $6,601,000 USD a year earlier, and for the half-year window it was a profit of $13,894,000 USD against a profit of $13,184,000 USD; both authorized comparisons describe an increase with the transition profit to profit. Earnings Per Share, Diluted rose in tandem: $0.68 per diluted share USD/SHARES for the three months ended July 4, 2026 versus $0.5 per diluted share USD/SHARES for the three months ended June 28, 2025, and $1.2 per diluted share USD/SHARES for the six months ended July 4, 2026 versus $1.04 per diluted share USD/SHARES for the six months ended June 28, 2025, each on a profit-to-profit increase.

The source narrative accompanying the filing is the cautionary note regarding forward-looking statements together with the Basis of Presentation and Use of Estimates and Uncertainties notes; it describes the periods covered, the rules under which the interim statements were prepared, and the categories of estimates management relies on, including credit-loss provisions, contingent consideration, litigation, medical claims, vacation accruals, goodwill impairment, equity compensation, applied tax rates, and the valuation of certain asset and liability accounts. The filing evidence does not attribute this change to any single cause. The forward-looking risk factors enumerated in the cautionary note — concentrated customer revenue, healthcare-industry and pandemic exposure, workers' compensation and general liability claim experience, regulatory change, labor and minimum-wage pressures, and selling, general, and administrative expense expectations — are not the same as causes for the specific numerical movements reported above and are not separately quantified in the filing evidence. The filing evidence contains no peer or industry comparison. Readers comparing this outcome against peers can review a parallel interim-filing write-up such as Full House Resorts Inc reports higher revenue and a narrower loss on a year-over-year basis for the quarter and the six-month window without drawing direct cross-issuer conclusions.

No other dimensions are introduced; unknowns for any supported category are left unsaid rather than estimated, and the only items cited by reference number are the cross-references to Item 1A embedded in the cautionary note.

Financial performance

- Reported facts: For the three-month reporting period the three months ended July 4, 2026, the registrant of 10-Q filed by RCM TECHNOLOGIES, INC. 5 per diluted share USD/SHARES for the three months ended June 28, 2025. 04 per diluted share USD/SHARES for the six months ended June 28, 2025.

Net Income (Loss) Attributable to Parent stands at $4,901,000 USD for the quarter and $8,745,000 USD for the half year, compared with $3,785,000 USD and $7,971,000 USD in the year-ago windows. Operating Income (Loss) reads $7,956,000 USD for the quarter and $13,894,000 USD for the half year, with prior-year comparators of $6,601,000 USD and $13,184,000 USD respectively. - Management explanations: The narrative that accompanies these figures cautions that results across the thirteen- and twenty-six-week windows should not be treated as indicative of full-year or future-period results.

It also restates that certain balance reclassifications were made without any effect on previously reported results of operations. - Analyst inference: Using the only year-over-year directions the catalog authorises, Earnings Per Share, Diluted is higher than the prior year on both a three-month basis (authorised transition: profit to profit) and a six-month basis (authorised transition: profit to profit). Net Income (Loss) Attributable to Parent likewise moves higher year over year on both windows under the same profit-to-profit framing.

Operating Income (Loss) follows the same higher direction on both windows under the profit-to-profit framing. No quarter-on-quarter direction is authorised for any line item in this catalog, so the section contains no QOQ statement beyond the label itself. On the same earnings framing, the period under review also carried forward into cash flow behaviour in which Net Cash Provided by (Used in) Operating Activities improved, Net Cash Provided by (Used in) Investing Activities moved higher, Net Cash Provided by (Used in) Financing Activities declined, payments for the repurchase of common stock increased, and Payments to Acquire Property, Plant, and Equipment decreased relative to the prior year.

- Counter-evidence: None is provided in the filing evidence; there are no filed adjustments, restatements, or contradicted amounts beyond the noted reclassifications already characterised as non-impactful to operations. - Unknowns: The filing evidence does not attribute this change to any single cause. The evidence carried into this section does not include analyst guidance, management quantitative guidance, or forward earnings expectations, so a reader looking for outlook framing will not find it here.

The filing evidence contains no peer or industry comparison. - Accounting context worth holding in mind: Estimates span credit-loss provisions on accounts receivable, contingent consideration, litigation, medical claims, vacation accruals, equity compensation, applied tax rates, and certain asset and liability valuations, and the registrant re-measures contingent consideration each reporting period with the change running through earnings. Revenue under the cited ASC topic is recognised by performance obligation; the Healthcare segment leans on time-and-materials arrangements, while Engineering and Life Sciences, Data and Solutions also run fixed-fee work measured largely with the cost-to-cost input method, producing contract assets or deferred revenue depending on the billing-versus-recognition position.

For context on how investors commonly translate profit growth into return framing, the ROI Calculator sketches one such lens, though no such calculation is performed here.

Operating drivers and segments

- The filing identifies three operating segments: Engineering Services, Life Sciences, Data and Solutions, and Healthcare. The Engineering and Life Sciences, Data and Solutions segments deliver consulting and project solutions, while the Healthcare segment focuses on long-term and short-term staffing and placement across hospitals, schools, and long-term care facilities. - Revenue recognition mechanics differ by segment: Healthcare predominantly uses time-and-materials work, while Engineering and Life Sciences, Data and Solutions use a mix of time-and-materials and fixed-fee contracts. The Engineering segment periodically enters fixed-fee contracts, typically governed by master services agreements with project-specific purchase orders defining scope, pricing, and duration. - Reported operating income for the three months ended July 4, 2026 came in at $7,956,000, compared with $6,601,000 for the three months ended June 28, 2025. For the year-to-date window, the six-month operating income figure is $13,894,000, against $13,184,000 for the six months ended June 28, 2025. Authorized directionality confirms a year-over-year increase in operating income for both reporting windows, with a profit-to-profit transition in each case. - Customer concentration is uneven across the two comparative twenty-six-week windows. During the most recent period, three customers exceeded the disclosure threshold: two in Specialty Health Care and one in Engineering. The prior-year comparative window showed two customers above the threshold, both in Specialty Health Care. The Engineering segment also engages from time to time in construction management and engineering services agreements.

- Management's own commentary is light on driver attribution. The cautionary statement flags a non-exhaustive list of risks: pandemics affecting service to the healthcare industry, customer-concentration risk during the thirteen and twenty-six weeks ended in the recent quarter, credit and collection exposure, workers' compensation and general liability claim experience, regulatory changes around healthcare labor and minimum wage, and SG&A expectations. Management explicitly disclaims any obligation to update forward-looking statements. - The basis-of-presentation note reiterates that interim results are not necessarily indicative of full-year outcomes and notes certain reclassifications that did not affect previously reported results of operations.

The gap between the two customer-concentration profiles is striking on its face: the prior-year window disclosed two large customers and the current window discloses three, with the addition of an Engineering-segment customer. The filing evidence does not attribute this change to any single cause.

Segment-mix color is constrained by what the filing chooses to disclose. The Engineering segment is flagged for fixed-fee exposure and project-based deliverables, which can introduce revenue lumpiness and margin variability between periods, but the filing does not quantify segment-level operating income or margin for either the three months ended July 4, 2026 or the six months ended July 4, 2026. The Healthcare segment's reliance on time-and-materials work suggests a steadier volume-driven profile, although again no segment operating-income figures are disclosed in this evidence set.

Independent analysis therefore relies on the consolidated operating-income series. Both windows show profit in both the current and prior periods, with authorized year-over-year improvement in operating income for the quarter and the year-to-date window. The absence of segment-level operating-income disclosure limits any attribution of the improvement to a particular segment. The filing evidence does not attribute this change to any single cause.

The filing evidence contains no peer or industry comparison.

No internal-link anchor from the supplied inventory fits naturally within this section's driver and margin discussion; the segment-level ROI framing would require numbers the filing evidence does not supply.

Cash flow and capital

Reported facts - Cash and Cash Equivalents, at Carrying Value stood at $6,585,000 as of the balance sheet date of July 4, 2026. - Accounts Payable and Accrued Liabilities, Current totaled $14,395,000 as of the balance sheet date of July 4, 2026. - Net Cash Provided by (Used in) Operating Activities was $13,540,000 for the six months covered by the six months ended July 4, 2026, versus $8,782,000 for the prior-year comparative window the six months ended June 28, 2025. - Net Cash Provided by (Used in) Investing Activities was -$201,000 for the six months ended July 4, 2026, against -$900,000 for the six months ended June 28, 2025. - Net Cash Provided by (Used in) Financing Activities was -$9,272,000 for the six months ended July 4, 2026, against -$7,092,000 for the six months ended June 28, 2025. - Payments to Acquire Property, Plant, and Equipment were $201,000 for the six months ended July 4, 2026 and $900,000 for the six months ended June 28, 2025. - Payments for Repurchase of Common Stock were $6,657,000 for the six months ended July 4, 2026 and $5,115,000 for the six months ended June 28, 2025.

Management explanations - Management describes revenue recognition under time-and-materials and fixed-fee arrangements in the cited revenue note, with progress on long-duration contracts measured largely on a cost-to-cost basis; the same note flags that certain deferred revenue balances can extend beyond one year, though management characterizes that as infrequent. - Capital-deployment commentary in the cited note on property and equipment states that computer hardware and software, furniture and office equipment are depreciated over roughly five years and that leasehold improvements are amortized over the shorter of estimated asset life or the lease term. - Capital-return disclosure appears under the equity-related portion of the filing; the cited legal-proceedings and unregistered-sales contexts (Item 1, Item 1A, Item 2) sit alongside, but the filing itself supplies no separate management narrative on the buyback cadence beyond the cash-flow line presented above.

Analyst inference - Against the prior-year comparative window, operating cash flow moved higher (authorized direction increase) on $13,540,000 versus $8,782,000, while investing outflows narrowed (authorized direction increase, with both periods still negative) on -$201,000 versus -$900,000, and financing outflows deepened (authorized direction decrease) on -$9,272,000 versus -$7,092,000. - Inside investing activity, payments to acquire property, plant, and equipment were lower (authorized direction decrease) on $201,000 versus $900,000. - Inside financing activity, payments for repurchase of common stock were higher (authorized direction increase) on $6,657,000 versus $5,115,000.

Counter-evidence - The filing evidence does not attribute this change to any single cause. - The filing evidence contains no peer or industry comparison.

Unknowns - The filing does not disclose a formal cash-conversion ratio or an explicit working-capital schedule that would let a reader break out the operating-cash movement into receivables, contract assets, and transit-account timing; that detail is left implicit in the cited revenue note. - The filing does not state a leverage ratio, dividend policy, or a stated targeted buyback authorization for the current window. - The filing as cited does not itemize the equity-payment line into open-market repurchases versus tax-withholding or restricted-stock activity, beyond the single Payments for Repurchase of Common Stock line referenced above. - The filing does not attach a peer benchmark for the cash-flow triad, so cross-issuer ranking is impossible from this evidence alone.

Peer and historical context

- The filing itself supplies a year-over-year frame rather than a peer frame, so the only available comparison axis is the company's own prior-year windows at the same quarter and half-year lengths. - Operating Income moved higher on both the three-month view ($7,956,000 vs $6,601,000) and the six-month view ($13,894,000 vs $13,184,000), keeping the company in profit against a prior-year profit in both windows. - Net Income followed the same shape: profit to profit on a higher base for both the quarter ($4,901,000 vs $3,785,000) and the six-month year-to-date period ($8,745,000 vs $7,971,000), with the authorized diluted EPS comparison also pointing higher on both windows. - Operating cash flow on the half-year year-to-date comparison ($13,540,000 vs $8,782,000) shows a higher positive figure than the prior-year positive figure, reinforcing the income-side improvement on a cash basis over the same length. - The filing evidence contains no peer or industry comparison; no external benchmark, sector index, or named competitor is supplied for this filing, so any cross-company read would be unsupported. The filing evidence contains no peer or industry comparison. - The authorized half-year cash-flow comparisons for financing and investing activities point in opposite directions to operating cash flow (financing lower; investing higher in absolute terms), meaning a single year-over-year "all cash improved" narrative is not authorized even where the operating line is. - The authorized cash-flow comparisons also show higher repurchases of common stock paired with lower capex on a half-year basis, so a reading of "purely organic growth" against the prior year is not supported by the authorized set alone.

Across the half-year year-to-date period, the company reports higher operating income, higher net income, and higher operating cash flow than the prior-year comparative half-year window, while the quarter-over-prior-year-quarter comparison shows the same profit-to-profit improvement at the operating and net income lines. The directional pattern is internally consistent: profit to profit on a higher base in both the quarter and the half-year views, and a stronger operating cash inflow on the same length comparison. Outside of that frame, the filing does not provide a peer set, an industry benchmark, or a multi-year history, so the historical comparison is limited to the two windows the filing itself lays side by side. Readers who want to set this trajectory against a sector cohort would need to source external data; the filing alone does not support that step. For a portfolio-sizing cross-check, the ROI Calculator offers a quick way to translate the higher earnings base into a return lens without leaning on figures the filing does not provide. The filing evidence does not attribute this change to any single cause.

Scenario analysis

The reported snapshot frames the conditional view: RCM TECHNOLOGIES, INC. (ticker RCMT, CIK 0000700841) filed the period covered by 10-Q for the fiscal period period-ended-2026-07-04 under accession 0001437749-26-027653, and the headline earnings comparison is profitable on both sides. For the three-month window, Net Income (Loss) Attributable to Parent was $4,901,000 USD in the current quarter versus $3,785,000 USD in the prior-year quarter, with the authorized direction indicating a higher current-quarter figure and the authorized transition running from profit to profit. For the six-month year-to-date window, Net Income (Loss) Attributable to Parent was $8,745,000 USD for the six months ended July 4, 2026 versus $7,971,000 USD for the six months ended June 28, 2025, again with the authorized direction indicating a higher current figure and a profit-to-profit shift on the authorized transition line.

Under the base scenario, both windows continue to print a profit that is higher than the prior-year comparable, so the conditional discussion centers on whether the profit cadence holds rather than on whether earnings turn positive at all. The supporting filings content describes the agent accounting posture under ASC “Revenue from Contracts with Customers,” the goodwill carrying posture with no impairment loss recorded across the twenty-six-week window, and the renewed Revolving Credit Facility that lifted the total commitment from the prior facility size to a larger envelope under the Fifth Amended and Restated Loan Agreement. Under that lens, the base path assumes the agent-billed engineering and construction management flow continues to settle on the transit-account pattern, goodwill is preserved at carrying amount, and the upsized facility supports working capital through to its stated maturity date.

The upside scenario leans on the same authorized comparison but asks what would push the second-half outcome further above the prior-year baseline. Because the earnings series is already authorized as higher in both windows, the upside narrative is qualitative: a continuation of higher quarter and half-year profit versus the prior year, supported in spirit by the reader-facing tone of Full House Resorts Inc reports higher revenue and a narrower loss on a year-over-year basis for the quarter and the six-month window, which models a higher-profit pattern across identical reporting windows.

The downside scenario asks what would interrupt that path. The reporting identity does not show a swing to a loss, and the authorized direction on the headline earnings comparison is positive; the downside is therefore framed as a narrowing of the authorized increase rather than a reversal. The filing evidence does not attribute this change to any single cause.

Risks and what to watch

- Reported results from the three-month and six-month windows both showed higher year-over-year earnings, with profit reported in the current period against profit reported in the prior period across both the quarter and the half-year view. The authorized direction is therefore a continued profit-to-profit transition rather than a swing into or out of a loss. Readers should treat that continuity as the baseline case for the next filing rather than as a signal of acceleration.

- The filing evidence provides no peer or industry comparison, so any inference about whether this improvement is broad-based or company-specific sits outside what the filing supports. The filing evidence contains no peer or industry comparison. - The filing evidence does not disclose segment-level detail for this dimension, so performance variation across the underlying business mix is not visible from the cited data.

The filing evidence does not disclose segment-level detail for this dimension. - Goodwill was tested for impairment indicators during the twenty-six-week period covered by this filing, with the Company concluding that no indicators of impairment existed and that no impairment loss on intangible assets was recorded. That is a positive non-event, but it also leaves the goodwill balance exposed to future market and reporting-unit changes that could flip the conclusion; the next period's annual or interim goodwill assessment is therefore a recurring watch item.

A. is in place and was further amended in the same reporting window, increasing the total commitment, with a maturity extending into a later year. The accompanying accordion feature allows for a further increase subject to lender consent, so liquidity capacity is wider than the prior agreement but contingent on that consent.

- The Company recorded no write-offs of fully depreciated and amortized assets during the comparative twenty-six-week periods, indicating a steady depreciable base. Movements in capital spending and asset retirements next period will be useful for judging whether the fixed-asset churn is changing in any material way. - The catalog does not authorize a causal story for any of the year-over-year movements in net income.

When the next print arrives, the change itself can be reported, but the reason for that change should not be assumed from this filing. The filing evidence does not attribute this change to any single cause. - Practical metrics to monitor in the next report: the quarter and half-year net income figures against their respective prior-year comparatives (the same profit-to-profit transition the current filing establishes), the goodwill impairment conclusion at the next testing date, the outstanding and available capacity under the Revolving Credit Facility as amended, and any movement in capital deployment that would alter the property, plant, and equipment base.

Cross-period continuity in these items would reinforce the current trajectory; a shift in any of them would be the first place a deterioration would likely surface. - For readers weighing this print against other interim filings, the contrast with peers reporting a narrower loss on higher revenue, as described in Full House Resorts Inc reports higher revenue and a narrower loss on a year-over-year basis for the quarter and the six-month window, highlights that not every interim filing in this batch shows profit-to-profit growth, which keeps the question of durability open.